News & Updates

  • PARSIPPANY, NJ -- LINEA System, a leader in accelerating clinical study start-up, announced today that it has been certified as a Minority/Women-Owned Business Enterprise (MWBE) by the State of New Jersey.  “Earning our Minority/Women-Owned Business Enterprise certification is representative of the values and standards we hold ourselves to, and of those to which we hold…
  • Thursday, September 24th @ 2:00pm EDT. Thank you for attending our webinar! We hope you enjoyed it and invite you to watch it on-demand.   Click here to watch.   Our speakers are: Host: Kathleen Colatrella - Founder & President of LINEA System Guest Speaker: Kari Brown, Director of Clinical Operations at DZS Clinical Services      
  •   PARSIPPANY, NJ and OAKLAND, CA - LINEA System, LLC and Trial By Fire Solutions, LLC have begun a partnership to offer their clinical trial solutions, AcceleTrial™ and SimpleTrials, respectively, as a fully integrated solution. This partnership will allow sponsors to take advantage of AcceleTrial™’s study start-up benefits to select and activate the right sites,…
  • By: Sarah Hof   Countless industries are shifting to virtual and remote operations, and the realm of clinical trials is no exception. In fact, COVID-19 has only accelerated our industry’s dependence on technology to efficiently and successfully run trials. This shift has prompted the field to accept virtual or decentralized clinical trials as a trusted…
  •   LINEA System is proud to have been recognized by MD Tech Review as a Top eClinical Trial Management Solution Provider for our work to accelerate clinical trials! To read the full story and see the spread, please visit their website, or click the PDF below.  “AcceleTrial™ identifies sites based on objective data validating therapeutic…
  •   Thank you to all who signed up for and attended our recent webinar, Optimizing Study Start-up in a Decentralized World, on Thursday 9/24! We're pleased to offer both the recording and the deck used during the presentation.  Recording - please click here. Slide deck - please click here.        
  • Thursday, September 24th @ 2:00pm EDT. Thank you for attending our webinar! We hope you enjoyed it and invite you to watch it on-demand.   Click here to watch.   Our speakers are: Host: Kathleen Colatrella - Founder & President of LINEA System Guest Speaker: Kari Brown, Director of Clinical Operations at DZS Clinical Services      
  • By Karen Ledesma Diversity and inclusion are imperative pieces when conducting clinical trials, but they continue to fall short at representing the diverse population. Factors such as differences in age, ethnicity, race, and gender may yield distinctive results in people when responding to the same treatment. When including a diverse population, one will be able…
  • By Sarah Hof Decentralized trials are here to stay, and major pharma companies have already bought into their effectiveness, as reported by FierceBiotech. While the operational component of decentralized or remote trials once posed a logistical hindrance, the pandemic has forced rapid advancements in the means to ensure an increasingly smooth experience for both patients…
  • Source: By Sumana Iyengar, CEO and Co-Founder of Goavega   (Health Vision) -- In current challenging times of pandemic, technology has proved to be a vital lifesaver for several industries, including healthcare. With social distancing norms, a series of essential services have moved to the online platform to serve their consumers better, while avoiding physical contact.…
  • By: Sarah Hof It’s no longer surprising to hear that many aspects of the pharmaceutical industry have been disrupted due to the far-reaching effects of COVID-19. Clinical trials are no exception, due to the myriad of moving parts it takes to conduct a clinical trial effectively. Hospital maintenance, doctor availability, and the willingness of patients…
  • By: Sarah Hof   Countless industries are shifting to virtual and remote operations, and the realm of clinical trials is no exception. In fact, COVID-19 has only accelerated our industry’s dependence on technology to efficiently and successfully run trials. This shift has prompted the field to accept virtual or decentralized clinical trials as a trusted…
  • By Sarah Hof Countless aspects of clinical trial operations have been disrupted in the last 10 months. To explore new pain points and shifts in trial planning across the industry as a result of the pandemic, GlobalData conducted a survey to gather metrics from professionals across the world, as reported by Pharmaceutical Technology. Overall, GlobalData…
  • By Sarah Hof Decentralized trials are here to stay, and major pharma companies have already bought into their effectiveness, as reported by FierceBiotech. While the operational component of decentralized or remote trials once posed a logistical hindrance, the pandemic has forced rapid advancements in the means to ensure an increasingly smooth experience for both patients…
  • By: Sarah Hof It’s no longer surprising to hear that many aspects of the pharmaceutical industry have been disrupted due to the far-reaching effects of COVID-19. Clinical trials are no exception, due to the myriad of moving parts it takes to conduct a clinical trial effectively. Hospital maintenance, doctor availability, and the willingness of patients…